Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...

According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...

HBV=hepatitis B virus. HBVDR=HBV drug resistance. i-GAP=integrated Global Action Plan ... Due to the overlapping reading frames in the HBV genome, RAMs in reverse transcriptase can also lead to ...

Tran’s two children received hepatitis B immunisations and injections of antibodies at birth to ensure they did not contract the disease. She has not needed to take antiviral medication.

UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that ... IgE candidates targeting various tumour-associated antigens, all in preclinical stages. Both companies completed ...

Abstract: The specific binding between antibodies (Ab) and antigens (Ag) is crucial for developing drugs and vaccines to treat major diseases. Therefore, accurate identification of antibody-antigen ...

Finally, the scientists added two antibodies to different "fingers ... of-care test to simultaneously detect HIV, hepatitis B and hepatitis C antigens, acknowledging the higher prevalence of ...